Annual accounts receivable:
$45.28M+$4.67M(+11.51%)Summary
- As of today (May 21, 2025), DVAX annual accounts receivable is $45.28 million, with the most recent change of +$4.67 million (+11.51%) on December 31, 2024.
- During the last 3 years, DVAX annual accounts receivable has fallen by -$70.94 million (-61.04%).
- DVAX annual accounts receivable is now -68.80% below its all-time high of $145.13 million, reached on December 31, 2022.
Performance
DVAX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$54.92M+$9.64M(+21.30%)Summary
- As of today (May 21, 2025), DVAX quarterly accounts receivable is $54.92 million, with the most recent change of +$9.64 million (+21.30%) on March 1, 2025.
- Over the past year, DVAX quarterly accounts receivable has increased by +$10.76 million (+24.37%).
- DVAX quarterly accounts receivable is now -72.59% below its all-time high of $200.36 million, reached on September 30, 2021.
Performance
DVAX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DVAX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.5% | +24.4% |
| 3 y3 years | -61.0% | -59.0% |
| 5 y5 years | +409.6% | +575.2% |
DVAX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.8% | +11.5% | -68.1% | +35.3% |
| 5 y | 5-year | -68.8% | +409.6% | -72.6% | +5982.5% |
| alltime | all time | -68.8% | +6472.0% | -72.6% | >+9999.0% |
DVAX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $54.92M(+21.3%) |
| Dec 2024 | $45.28M(+11.5%) | $45.28M(-38.3%) |
| Sep 2024 | - | $73.33M(+18.9%) |
| Jun 2024 | - | $61.65M(+39.6%) |
| Mar 2024 | - | $44.16M(+8.8%) |
| Dec 2023 | $40.61M(-72.0%) | $40.61M(-12.4%) |
| Sep 2023 | - | $46.35M(+7.2%) |
| Jun 2023 | - | $43.24M(-57.5%) |
| Mar 2023 | - | $101.74M(-29.9%) |
| Dec 2022 | $145.13M(+24.9%) | $145.13M(+11.8%) |
| Sep 2022 | - | $129.77M(-24.7%) |
| Jun 2022 | - | $172.27M(+28.6%) |
| Mar 2022 | - | $133.97M(+15.3%) |
| Dec 2021 | $116.22M(+421.0%) | $116.22M(-42.0%) |
| Sep 2021 | - | $200.36M(+89.2%) |
| Jun 2021 | - | $105.90M(+26.1%) |
| Mar 2021 | - | $83.99M(+276.6%) |
| Dec 2020 | $22.30M(+151.0%) | $22.30M(-36.3%) |
| Sep 2020 | - | $35.02M(+3778.5%) |
| Jun 2020 | - | $903.00K(-88.9%) |
| Mar 2020 | - | $8.13M(-8.5%) |
| Dec 2019 | $8.89M(+139.9%) | $8.89M(+0.7%) |
| Sep 2019 | - | $8.82M(+16.4%) |
| Jun 2019 | - | $7.58M(+30.9%) |
| Mar 2019 | - | $5.79M(+56.3%) |
| Dec 2018 | $3.70M(+333.7%) | $3.70M(+145.8%) |
| Sep 2018 | - | $1.51M(+15.6%) |
| Jun 2018 | - | $1.30M(+70.9%) |
| Mar 2018 | - | $763.00K(-10.7%) |
| Dec 2017 | $854.00K(-36.4%) | $854.00K(+9.1%) |
| Sep 2017 | - | $783.00K(-3.3%) |
| Jun 2017 | - | $810.00K(-44.7%) |
| Mar 2017 | - | $1.47M(+9.2%) |
| Dec 2016 | $1.34M(-3.7%) | $1.34M(-41.4%) |
| Sep 2016 | - | $2.29M(+22.9%) |
| Jun 2016 | - | $1.86M(+60.1%) |
| Mar 2016 | - | $1.16M(-16.5%) |
| Dec 2015 | $1.39M(+91.7%) | $1.39M(+19.9%) |
| Sep 2015 | - | $1.16M(+77.0%) |
| Jun 2015 | - | $657.00K(-27.7%) |
| Mar 2015 | - | $909.00K(+25.0%) |
| Dec 2014 | $727.00K | $727.00K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $727.00K(-43.7%) |
| Jun 2014 | - | $1.29M(-25.3%) |
| Mar 2014 | - | $1.73M(+6.3%) |
| Dec 2013 | $1.63M(+61.9%) | $1.63M(-24.6%) |
| Sep 2013 | - | $2.16M(+6.6%) |
| Jun 2013 | - | $2.02M(+30.9%) |
| Mar 2013 | - | $1.55M(+53.9%) |
| Dec 2012 | $1.00M(-89.5%) | $1.00M(-72.7%) |
| Sep 2012 | - | $3.69M(+187.0%) |
| Jun 2012 | - | $1.28M(-6.6%) |
| Mar 2012 | - | $1.38M(-85.6%) |
| Dec 2011 | $9.53M(+851.7%) | $9.53M(+1116.7%) |
| Sep 2011 | - | $783.00K(-31.3%) |
| Jun 2011 | - | $1.14M(+1.1%) |
| Mar 2011 | - | $1.13M(+12.6%) |
| Dec 2010 | $1.00M(+11.8%) | $1.00M(-20.2%) |
| Sep 2010 | - | $1.25M(-7.0%) |
| Jun 2010 | - | $1.35M(+17.1%) |
| Mar 2010 | - | $1.15M(+28.7%) |
| Dec 2009 | $895.00K(-86.0%) | $895.00K(-24.4%) |
| Sep 2009 | - | $1.18M(-22.1%) |
| Jun 2009 | - | $1.52M(-49.0%) |
| Mar 2009 | - | $2.98M(-53.5%) |
| Dec 2008 | $6.41M(-11.4%) | $6.41M(+3.1%) |
| Sep 2008 | - | $6.22M(-22.8%) |
| Jun 2008 | - | $8.06M(+31.2%) |
| Mar 2008 | - | $6.14M(-15.1%) |
| Dec 2007 | $7.23M(+235.8%) | $7.23M(+1160.3%) |
| Sep 2007 | - | $574.00K(-47.9%) |
| Jun 2007 | - | $1.10M(-9.5%) |
| Mar 2007 | - | $1.22M(-43.5%) |
| Dec 2006 | $2.15M(+212.6%) | $2.15M(+14.3%) |
| Sep 2006 | - | $1.89M(+165.5%) |
| Jun 2006 | - | $710.00K(+68.6%) |
| Mar 2006 | - | $421.00K(-38.9%) |
| Dec 2005 | $689.00K(-78.0%) | $689.00K(-35.1%) |
| Sep 2005 | - | $1.06M(+42.6%) |
| Jun 2005 | - | $744.00K(-91.7%) |
| Mar 2005 | - | $8.96M(+186.1%) |
| Dec 2004 | $3.13M | $3.13M(-11.7%) |
| Sep 2004 | - | $3.54M(-22.5%) |
| Jun 2004 | - | $4.57M |
FAQ
- What is Dynavax Technologies annual accounts receivable?
- What is the all time high annual accounts receivable for Dynavax Technologies?
- What is Dynavax Technologies annual accounts receivable year-on-year change?
- What is Dynavax Technologies quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Dynavax Technologies?
- What is Dynavax Technologies quarterly accounts receivable year-on-year change?
What is Dynavax Technologies annual accounts receivable?
The current annual accounts receivable of DVAX is $45.28M
What is the all time high annual accounts receivable for Dynavax Technologies?
Dynavax Technologies all-time high annual accounts receivable is $145.13M
What is Dynavax Technologies annual accounts receivable year-on-year change?
Over the past year, DVAX annual accounts receivable has changed by +$4.67M (+11.51%)
What is Dynavax Technologies quarterly accounts receivable?
The current quarterly accounts receivable of DVAX is $54.92M
What is the all time high quarterly accounts receivable for Dynavax Technologies?
Dynavax Technologies all-time high quarterly accounts receivable is $200.36M
What is Dynavax Technologies quarterly accounts receivable year-on-year change?
Over the past year, DVAX quarterly accounts receivable has changed by +$10.76M (+24.37%)